Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

JSFC Sistema helped Segezha Group to pass the bond offer

12/1/23 SGZH

Lukoil may get the largest oil field in Iraq

11/30/23 LKOH

Lukoil received a license for an area in Perm Krai

11/30/23 LKOH

Sovcombank reported for 9 months of 2023 according to IFRS

11/30/23 SVCB

Yandex will start leasing Rovers to other companies

11/30/23 YNDX

Sovcombank acquired insurance company InLife

11/30/23 SVCB

Prices for Rostelecom's services to competitors may increase by 10%

11/30/23 RTKM

SPB Exchange will launch a number of new projects in early 2024

11/30/23 SPBE

INARCTICA completes SPO with oversubscription

11/30/23 AQUA

Rosneft reported for 9 months of 2023 by IFRS

11/30/23 ROSN